Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Mem. Inst. Oswaldo Cruz ; 110(2): 166-173, 04/2015. tab, graf
Article in English | LILACS | ID: lil-744479

ABSTRACT

Despite recent advances in the treatment of some forms of leishmaniasis, the available drugs are still far from ideal due to inefficacy, parasite resistance, toxicity and cost. The wide-spectrum antimicrobial activity of 2-nitrovinylfuran compounds has been described, as has their activity against Trichomonas vaginalis and other protozoa. Thus, the aim of this study was to test the antileishmanial activities of six 2-nitrovinylfurans in vitro and in a murine model of leishmaniasis. Minimum parasiticide concentration (MPC) and 50% inhibitory concentration (IC50) values for these compounds against the promastigotes of Leishmania amazonensis, Leishmania infantum and Leishmania braziliensis were determined, as were the efficacies of two selected compounds in an experimental model of cutaneous leishmaniasis (CL) caused by L. amazonensis in BALB/c mice. All of the compounds were active against the promastigotes of the three Leishmania species tested. IC50 and MPC values were in the ranges of 0.8-4.7 µM and 1.7-32 µM, respectively. The compounds 2-bromo-5-(2-bromo-2-nitrovinyl)-furan (furvina) and 2-bromo-5-(2-methyl-2-nitrovinyl)-furan (UC245) also reduced lesion growth in vivo at a magnitude comparable to or higher than that achieved by amphotericin B treatment. The results demonstrate the potential of this class of compounds as antileishmanial agents and support the clinical testing of Dermofural(r) (a furvina-containing antifungal ointment) for the treatment of CL.


Subject(s)
Humans , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hodgkin Disease/drug therapy , Hodgkin Disease/pathology , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bleomycin/adverse effects , Bleomycin/therapeutic use , Combined Modality Therapy , Decision Making , Dacarbazine/adverse effects , Dacarbazine/therapeutic use , Doxorubicin/adverse effects , Doxorubicin/therapeutic use , Hodgkin Disease/mortality , Neoplasm Staging , Practice Guidelines as Topic , Risk Assessment , Treatment Outcome , Vinblastine/adverse effects , Vinblastine/therapeutic use
2.
Rev. cuba. med. trop ; 53(3): 180-188, sept.-dic. 2001. tab, graf
Article in Spanish | LILACS | ID: lil-327196

ABSTRACT

Se demostró que existe relación entre la concentración celular y la lectura de los parásitos en un lector de ELISA. Se determinó que la absorbancia tiene valores significativos en las longitudes de onda del rango visible y se escogió la longitud de onda mínima posible (450 nm) para garantizar un máximo de sensibilidad. Pudo comprobarse que ocurre un aumento significativo de la absorbancia (p<0,001) después de llenada la placa, que se estabiliza en el intervalo de 40 min hasta 4 h. Al aplicar 100, 150, 200 ó 300 µL por pozo de las diferentes concentraciones de células se demostró que el volumen óptimo era de 150 µL, se obtuvo un r2 = 0,9986, y resultaron altamente significativos el coeficiente de correlación (p<0,001) y la pendiente (p<0,001). En el intervalo de 5 x 104 a 1,5 x 107 células/mL se obtuvo un coeficiente de variación medio de 1,75 porciento (0,25-3,17 porciento). En estas condiciones el límite de cuantificación fue de 5,14 x 104 células/mL. Por último se demostró que hubo significación de la correlación entre el conteo en cámara de Neubauer y la densidad óptica


Subject(s)
Diffusion Chambers, Culture , Trichomonas vaginalis
SELECTION OF CITATIONS
SEARCH DETAIL